Comunicato Stampa Press Release

PRESS RELEASE PURSUANT TO ART. 114 TUF

Milan, 25 March 2019 - Aedes SIIQ S.p.A. (MTA: RST) announces that it has received, from the majority shareholder Augusto S.p.A. ("Augusto"), holder of a total stake equal to 51.28% of the share capital of Aedes SIIQ S.p.A., a communication sent by Arepo AD S.à r.l. ("Arepo"), a company incorporated under Luxembourg law - indirectly wholly owned by Sator Capital Limited through Sator Investment S.à.r.l. - holder of a 30.08% stake in the share capital of Augusto, whose object is to launch, starting from 3 December 2019, the first effective date pursuant to the statute of Augusto, the forced sale procedure of 100 % of the share capital of Augusto and / or 100% of the investments held by Augusto in Aedes SIIQ SpA and in Restart SIIQ S.p.A..

Within 30 days after the receipt of the formal communication of the start of the sale procedure, including the name of an international top level independent financial advisor to entrust the task for the aforementioned procedure, each member of Augusto may present the other members with an irrevocable offer for the cash purchase of all the shares held by each shareholder in Augusto at the highest value between: (i) the value of the contributions made by each shareholder in Augusto for the subscription of the relative shares, increased according to the methods and terms indicated in the social statute of Augusto; and (ii) the market value of Augusto's shares.

Otherwise, the appointed financial advisor will organize a sales procedure according to the best market standards for the sale of the entire share capital of Augusto and / or of the entire investments held by Augusto in Aedes SIIQ S.p.A. and in Restart SIIQ S.p.A..

It should be noted that Arepo also announced its willingness to evaluate the participation in any financial support interventions by Augusto in favor of Aedes SIIQ S.p.A. that are functional to the maximization of the liquidation value of the aforesaid participation within the sales procedure.

For more information on the methods and terms of the sale procedure, please refer to the essential information relating to the provisions of Augusto's bylaws available on the Aedes SIIQ website, atwww.aedes-siiq.com(section: Corporate Governance / Company Documents / Shareholder Agreements).

For further information:www.aedes-siiq.com

Investor Relations

Aedes SIIQ S.p.A.

Tel. +39 02 6243.1

investor.relations@aedes-siiq.com

CDR Communication - Silvia Di Rosa

Mob. +39 335 7864209

silvia.dirosa@cdr-communication.it

Press Office

Lorenzo Morelli

Tel. +39 02 6243.1

l.morelli@aedes-siiq.com

Studio Noris Morano

Tel. +39 02 76004736-45

norismorano@studionorismorano.com

Attachments

  • Original document
  • Permalink

Disclaimer

Aedes SIIQ S.p.A. published this content on 25 March 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 March 2019 12:14:03 UTC